GT200000091A - Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos. - Google Patents

Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos.

Info

Publication number
GT200000091A
GT200000091A GT200000091A GT200000091A GT200000091A GT 200000091 A GT200000091 A GT 200000091A GT 200000091 A GT200000091 A GT 200000091A GT 200000091 A GT200000091 A GT 200000091A GT 200000091 A GT200000091 A GT 200000091A
Authority
GT
Guatemala
Prior art keywords
radical
atom
replaced
compounds
antifungicos
Prior art date
Application number
GT200000091A
Other languages
English (en)
Inventor
Patrick Fauveau
Stephen Hawser
Giles Lebourg
Laurent Schio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000091A publication Critical patent/GT200000091A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE EQUINOCANDINA, (VER FORMULA I, DONDE R1 Y R2 SON IGUALES O DIFERENTES UNO DEL OTRO REPRESENTAN UN ATOMO DE HIDROGENO, UN RADICAL HIDROXILO, UN RADICAL ALQUILO QUE INCLUYE HASTA 8 ATOMOS DE CARBONO LINEAL, RAMIFICADO O CICLICO, EVENTUALMENTE INTERRUMPIDO POR UN ATOMO DE OXIGENO Y EVENTUALMENTE SUSTITUIDO CON UN ATOMO DE HALOGENO, UN RADICAL OH O UN GRUPO AMINO, O BIEN R1 FORMA CON EL ATOMO DE CARBONO ENDOCICLICO QUE LO PORTA EL RADICAL DE LA AMINA SUSTITUIDA, O R2 REPRESENTA UN RADICAL IMINO SUSTITUIDO; R3 REPRESENTA UN ATOMO DE HIDROGENO, CH3 O OH; T = H, CH3, AMIDA, NITRILO O AMINA; Y = H, OH, HALO, UN RADICAL BISULFATO O UNA DE LAS SALES DE ESTE RADICAL; W = H, CH3 O OH; Z = H O CH3. PARA UNA DESCRIPCION DETALLADA DEBERA BUSCARSE EN EL DOCUMENTO ORIGINAL LOS COMPUESTOS PREFERIDOS) SU PROCEDIMIENTO DE PREPARACION Y SU APLICACION COMO ANTIFUNGICOS, ESPECIALMENTE EFECTIVO PARA CANDIDA, TROPICALIS, ASPERGILLUS Y CREPTOCOCUS. LOS COMPUESTOS PUEDEN SER UTILIZADOS COMO MEDICAMENTOS EN UN SER HUMANO O ANIMAL, PARA LUCHAR CONTRA CANDIDOSIS INVASIVAS, DIGESTIVAS, URINARIAS, VAGINALES O CUTANEAS, CRIPTOCOSIS NEUROMENINGEAS O PULMONARES Y ASPERGILOSIS PULMONARES Y ASPERGILOSIS INVASIVA DE UN SUJETO INMUNODEPRIMIDO. LOS COMPUESTOS DE LA INVENCION NO ESTAN LIMITADOS A UNA UTILIZACION FARMACEUTICA Y PUEDEN SER IGUALMENTE UTILIZADOS COMO FUNGICIDAS EN OTROS CAMPOS DISTINTOS DEL FARMACEUTICO.
GT200000091A 1999-06-09 2000-06-08 Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos. GT200000091A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907251A FR2794746B1 (fr) 1999-06-09 1999-06-09 Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme anti-fongiques

Publications (1)

Publication Number Publication Date
GT200000091A true GT200000091A (es) 2001-11-30

Family

ID=9546548

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000091A GT200000091A (es) 1999-06-09 2000-06-08 Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos.

Country Status (18)

Country Link
US (2) US7022669B1 (es)
EP (1) EP1189933B1 (es)
JP (1) JP4493891B2 (es)
AR (1) AR024316A1 (es)
AT (1) ATE236928T1 (es)
AU (1) AU5688400A (es)
CA (1) CA2376025C (es)
CO (1) CO5200766A1 (es)
DE (1) DE60002075T2 (es)
DK (1) DK1189933T3 (es)
ES (1) ES2192533T3 (es)
FR (1) FR2794746B1 (es)
GT (1) GT200000091A (es)
PE (1) PE20010332A1 (es)
PT (1) PT1189933E (es)
TN (1) TNSN00128A1 (es)
UY (1) UY26196A1 (es)
WO (1) WO2000075177A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
DE102004060750A1 (de) 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5464903A (en) * 1994-10-31 1995-11-07 E. I. Du Pont De Nemours And Company Process for preparing ethylene copolymer plasticized PVC
UA72200C2 (uk) * 1997-12-10 2005-02-15 Авентіс Фарма С.А. Похідні ехінокандину, спосіб їх одержання, їх застосування, проміжні сполуки та фармацевтична композиція
FR2794747B1 (fr) * 1999-06-09 2004-04-16 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme anti-fongiques

Also Published As

Publication number Publication date
WO2000075177A1 (fr) 2000-12-14
US20060035820A1 (en) 2006-02-16
UY26196A1 (es) 2001-01-31
EP1189933A1 (fr) 2002-03-27
CA2376025A1 (fr) 2000-12-14
EP1189933B1 (fr) 2003-04-09
CA2376025C (fr) 2010-06-01
AU5688400A (en) 2000-12-28
DE60002075T2 (de) 2003-11-20
FR2794746A1 (fr) 2000-12-15
FR2794746B1 (fr) 2002-12-06
DK1189933T3 (da) 2003-07-21
TNSN00128A1 (fr) 2002-05-30
US7022669B1 (en) 2006-04-04
ATE236928T1 (de) 2003-04-15
US7192920B2 (en) 2007-03-20
JP2003501441A (ja) 2003-01-14
AR024316A1 (es) 2002-09-25
PT1189933E (pt) 2003-08-29
PE20010332A1 (es) 2001-03-29
JP4493891B2 (ja) 2010-06-30
ES2192533T3 (es) 2003-10-16
CO5200766A1 (es) 2002-09-27
DE60002075D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
PE20070211A1 (es) Compuestos macrociclicos como inhibidores del virus de hepatitis c
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
DK531885A (da) Fremgangsmaade til desinfektion og middel dertil
WO2005065646A3 (en) Novel drug compositions and dosage forms
AR051404A1 (es) Composiciones de limpieza y desinfectantes
PL376176A1 (en) Solid preparation
ES2139071T3 (es) Agente insecticida y acaricida derivado del triazol y proceso para la produccion del mismo.
GT200000091A (es) Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos.
DE60205085D1 (de) Metallphthalocyanin-analoge enthaltende antibakterielle Zusammensetzungen
AR032553A1 (es) Derivados de alfa-amino-n-hidroxi-acetamida.
AR046143A1 (es) Composicion farmaceutica que contiene un derivado de tiourea con solubilidad y biodisponiblidad mejoradas
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
BR0102940A (pt) Agente para o tratamento de doença de parkinson compreendendo um agente de melhora da função de astrócitos como ingrediente ativo
HUP0301040A2 (hu) Parazitaölő hatású 13 -szubsztituált milbemicinszármazékok, ezeket tartalmazó készítmények és alkalmazásuk
DE60104589D1 (de) Therapeutisches Mittel zur Behandlung von Dermatitis
AR015761A1 (es) Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades
DK1178960T3 (da) Vitamin D analoger og deres farmaceutiske anvendelse
AR040600A1 (es) Composicion farmaceutica estable que comprende eritropoietina
CN103814896B (zh) 一种消毒液及其制造而成的湿纸巾
ES2128529T3 (es) Derivados de oxazolina, procedimiento para su preparacion y composiciones agricolas y horticolas para el control de organismos nocivos que los contienen.
AU1454302A (en) Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
IL152699A (en) PHARMACEUTICAL FORMULATION OF 6-HYDROXY - 3 - (4 - [2 - (PIPERIDIN - 1 - YL) ETHOXY] PHENOXY) - 2 - (4 -METHOXYPHENYL) BENZO [b] THIOPHENE OR OF SALTS THEREOF, ITS USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES AND METHOD FOR STABILISING THE SAME
IL165996A0 (en) Novel thiophene acyl hydrazino derivatives method for preparing same use thereof as medicines pharmaceutical compositions and novel use